Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 247
Filtrar
Mais filtros

Intervalo de ano de publicação
1.
Eye Contact Lens ; 50(6): 243-248, 2024 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-38477759

RESUMO

OBJECTIVES: To determine the compliance of online vendors to the UK Opticians Act 1989 Section 27 requirements and safety regulations for cosmetic contact lens (CCL) sales and the quality of online CCL health information. METHODS: The top 50 websites selling CCLs on each three search engines, namely Google, Yahoo, and Bing, were selected. Duplicates were removed, and the remaining websites were systematically analyzed in February 2023. UK legal authorization for CCL sales was assessed using the Opticians Act Section 27 and safety regulations determined by the presence of Conformité Européene (CE) marking. The quality and reliability of online information was graded using the DISCERN (16-80) and JAMA (0-4) scores by two independent reviewers. RESULTS: Forty-seven eligible websites were analyzed. Only six (12.7%) met the UK legal authorization for CCL sales. Forty-nine different brands of CCLs were sold on these websites, of which 13 (26.5%) had no CE marking. The mean DISCERN and JAMA benchmark scores were 26 ± 12.2 and 1.3 ± 0.6, respectively (intraclass correlation scores: 0.99 for both). CONCLUSIONS: A significant number of websites provide consumers with easy, unsafe, and unregulated access to CCLs. Most online stores do not meet the requirements set out in the Opticians Act for CCL sales in the United Kingdom. A significant number of CCLs lack CE marking, while the average quality of information on websites selling CCLs is poor. Together, these pose a risk to consumers purchasing CCLs from unregulated websites, and therefore, further stringent regulations on the online sales of these products are needed.


Assuntos
Informação de Saúde ao Consumidor , Internet , Humanos , Reino Unido , Informação de Saúde ao Consumidor/normas , Cosméticos/normas , Lentes de Contato , Qualidade de Produtos para o Consumidor/legislação & jurisprudência , Qualidade de Produtos para o Consumidor/normas
2.
PLoS One ; 16(11): e0259298, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34739490

RESUMO

This paper explored the occurrence of food fraud and adulterations (FFA) in exports from the Association of South- East Asia Nations (ASEAN), with implications on food chain and international trade. Data from European Union Rapid Alert System for Food and Feed (EU RASFF) about FFA notifications on ASEAN exports for a period of 20 years (2000-2020) were extracted and analyzed. Results from this study revealed that of all ten ASEAN member countries, seven had cases of FFA notified in the database with Thailand (n = 47, 32%) and the Philippines (n = 37, 26%) receiving the highest frequency of notifications in the region. There was a statistical significance difference in frequency of notifications received on products from these seven countries with herbs and spices ranking highest (n = 22, 15%). Highest notifications of FFA on ASEAN exports came from the United Kingdom (n = 31, 21%). All the seven countries experienced border rejections and consequent destruction of food products especially on exports from Indonesia where 95% of product with FFA were border rejected. Border rejections on products from these countries were significantly different. Therefore, a thorough implementation system, appropriate testing and constantly updating each country's FFA database could aid actions in curtailing future events.


Assuntos
Contaminação de Alimentos/análise , Contaminação de Alimentos/estatística & dados numéricos , Fraude/tendências , Sudeste Asiático , Comércio/economia , Comércio/tendências , Qualidade de Produtos para o Consumidor/normas , Europa (Continente) , Alimentos/normas , Cadeia Alimentar , Contaminação de Alimentos/economia , Inocuidade dos Alimentos/métodos , Abastecimento de Alimentos/ética , Humanos , Incidência
3.
Regul Toxicol Pharmacol ; 125: 105026, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34389358

RESUMO

Next generation risk assessment (NGRA) is an exposure-led, hypothesis-driven approach that has the potential to support animal-free safety decision-making. However, significant effort is needed to develop and test the in vitro and in silico (computational) approaches that underpin NGRA to enable confident application in a regulatory context. A workshop was held in Montreal in 2019 to discuss where effort needs to be focussed and to agree on the steps needed to ensure safety decisions made on cosmetic ingredients are robust and protective. Workshop participants explored whether NGRA for cosmetic ingredients can be protective of human health, and reviewed examples of NGRA for cosmetic ingredients. From the limited examples available, it is clear that NGRA is still in its infancy, and further case studies are needed to determine whether safety decisions are sufficiently protective and not overly conservative. Seven areas were identified to help progress application of NGRA, including further investments in case studies that elaborate on scenarios frequently encountered by industry and regulators, including those where a 'high risk' conclusion would be expected. These will provide confidence that the tools and approaches can reliably discern differing levels of risk. Furthermore, frameworks to guide performance and reporting should be developed.


Assuntos
Alternativas aos Testes com Animais/métodos , Qualidade de Produtos para o Consumidor/normas , Cosméticos/normas , Medição de Risco
4.
Regul Toxicol Pharmacol ; 125: 105000, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34233207

RESUMO

In 2019, the Dutch Food and Consumer Product Safety Authority performed a market surveillance for toy-slime (23 samples) and putty (16 samples). For 35% of the toy-slimes and 13% of the putties, the migration of boron exceeded the European legal limit of 300 and 1200 mg/kg respectively. In 36% of the toy samples, methylisothiazolinone (MI) and chloromethylisothiazolinone (CMI) were detected in levels up to 25 and 38 mg/kg, respectively, much higher than the European legal limit for aqueous toys intended for children younger than three. 59% of the toys contained other preservatives such as 2-phenoxyethanol, p-hydroxybenzoic acid and parabens. In 2 toy-slimes and 2 putties N-nitrosodiethanolamine (NDELA) was found in amounts up to 2.3 mg/kg. A risk assessment was performed for boron and NDELA. The estimated exposure to boron did not exceed the health based guidance value. The estimated exposure to NDELA from 2 toy-slimes may pose a health risk. For 2 putties the estimated exposure to NDELA was somewhat lower, but health risks could not be excluded. The presence of isothiazolinones may lead to skin sensitisation. It is recommended to extend the legal limit for NDELA, MI and CMI in finger-paint and labelling requirements to other aqueous toys.


Assuntos
Qualidade de Produtos para o Consumidor/normas , Substâncias Perigosas/análise , Jogos e Brinquedos , Boro/análise , Humanos , Países Baixos , Tiazóis/análise
5.
J Food Sci ; 86(5): 2145-2162, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33928644

RESUMO

In this work, the occurrence of 34 common antibiotic (15 sulfonamides and 19 quinolones) residues were evaluated in 236 ready-to-eat duck eggs (salted and preserved duck eggs) marketed through e-commerce stores by ultra-performance liquid chromatography coupled to tandem mass spectrometry, and subsequent dietary risk assessments for Chinese consumers were conducted. Among violated positives in duck egg samples, 11 analytes were found including sulfamethazine, sulfaquinoxaline, sulfamethoxazole, sulfadiazine, sulfamonomethoxine, ciprofloxacin, enrofloxacin, ofloxacin, flumequine, sarafloxacin, and nalidixic acid. A higher number of antibiotics were detected in salted duck eggs (five sulfonamides and six quinolones) than in preserved duck eggs (one sulfonamide and two quinolones). The maximum contamination of sulfonamides and quniolones was 448.0 µg/kg (sulfaquinoxaline) and 563.7 µg/kg (enrofloxacin) in salted duck eggs, respectively. Dietary exposure was evaluated through the estimated daily intake (EDI) of risky antibiotics (sulfamethazine, ciprofloxacin, and enrofloxacin) and hazard quotients (HQs). The results showed that EDIs and HQs were in the range of 0.0004 to 0.0099 µg/kg bw/day and 0.0009 to 0.1594%, respectively. The risk was low since HQs obtained were less than 100%. However, a special attention should be paid to ready-to-eat duck egg products high percentile consumers with the prosperity of e-commerce market in China. PRACTICAL APPLICATION: The present analytical method could be used for multiresidue determination of antibiotics in ready-to-eat duck eggs, and dietary risk assessments of risky antibiotics provided a support for the work of regulatory bodies to conduct surveillance programs regarding food safety evaluation of ready-to-eat foods.


Assuntos
Antibacterianos/análise , Comércio/normas , Qualidade de Produtos para o Consumidor/normas , Ovos/análise , Contaminação de Alimentos/análise , Medição de Risco/métodos , Animais , China , Cromatografia Líquida/métodos , Patos , Espectrometria de Massas em Tandem/métodos
8.
J Toxicol Environ Health A ; 83(13-14): 509-524, 2020 07 17.
Artigo em Inglês | MEDLINE | ID: mdl-32552538

RESUMO

The labeling of all ingredients contained in consumer products has been requested by consumers concerned regarding their safety. Consequently, regulatory agencies have set guidelines for industries on how to provide safety information regarding the ingredients in their products. However, discordant opinions were raised from stakeholders, resulting in the formation of a risk communication forum among industries, regulatory agencies, consumer groups, and academia. There are several methods that might be utilized to provide ingredient information to consumers: (1) listing all ingredients on the label of products, (2) providing major ingredients on the label of products, (3) presenting all ingredients on the websites of each manufacturer, and (4) listing major ingredients on the label of products and the remainder of ingredients (not on the label) on the websites. Each method might have its own advantages and disadvantages with respect to providing the information regarding the names of the ingredients used in consumer products to the consumers. A continuous risk communication forum might be an effective tool to facilitate an improved understanding of chemical information, toxicological science, regulatory guidelines, labeling methods, and consumers' concern. This study suggests that risk communication efforts may be helpful and a good opportunity for stakeholders to exchange opinions and reach a harmonious conclusion on labeling of consumer products ingredients.


Assuntos
Comunicação , Qualidade de Produtos para o Consumidor/normas , Rotulagem de Produtos/normas , Cosméticos/normas , Produtos Domésticos/normas , Humanos , República da Coreia , Gestão de Riscos , Participação dos Interessados
9.
J Food Sci ; 85(5): 1542-1547, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32271959

RESUMO

The aims of this study were to establish a relationship between consumers' socioeconomic aspects, key meat attributes, and consumer perception and conduct toward traced beef in Brazil. The authors applied a structured form in 52 supermarkets in eight Brazilian cities, through interviews with 2.949 consumers, in 2012. Federal or state inspection stamp was the attribute that most influenced the consumers' purchase decision (14.1%). Most of the interviewees (57.3%) had never heard about bovine traceability. Among those who had heard about bovine traceability, 63.2% would be willing to pay more for beef with certified origin. Consumers with higher education and income had a better knowledge about this type of certification, as well as older consumers, and therefore they would be willing to pay more for certified beef. This research suggests that educational level was the reason that most influenced Brazilian consumers during beef purchase.


Assuntos
Qualidade de Produtos para o Consumidor/normas , Carne Vermelha/normas , Adulto , Animais , Brasil , Bovinos , Certificação , Comportamento do Consumidor/economia , Tomada de Decisões , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Controle de Qualidade
10.
Bone Joint J ; 102-B(2): 148-154, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-32009438

RESUMO

Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biological procedures. Such providers have been known to recommend, prescribe, or deliver so called 'stem cell' preparations without sufficient data to support their true content and efficacy. In this annotation, we outline the current environment of stem cell-based treatments and the strategies of marketing directly to consumers. We also outline the difficulties in the regulation of these clinics and make recommendations for best practice and the identification and reporting of illegitimate providers. Cite this article: Bone Joint J 2020;102-B(2):148-154.


Assuntos
Instituições de Assistência Ambulatorial/normas , Publicidade Direta ao Consumidor/normas , Marketing de Serviços de Saúde/normas , Doenças Musculoesqueléticas/cirurgia , Segurança do Paciente/normas , Transplante de Células-Tronco/normas , Instituições de Assistência Ambulatorial/legislação & jurisprudência , Qualidade de Produtos para o Consumidor/legislação & jurisprudência , Qualidade de Produtos para o Consumidor/normas , Publicidade Direta ao Consumidor/legislação & jurisprudência , Publicidade Direta ao Consumidor/tendências , Humanos , Marketing de Serviços de Saúde/legislação & jurisprudência , Marketing de Serviços de Saúde/tendências , Segurança do Paciente/legislação & jurisprudência , Guias de Prática Clínica como Assunto/normas , Transplante de Células-Tronco/legislação & jurisprudência , Transplante de Células-Tronco/tendências , Reino Unido , Estados Unidos
11.
Food Microbiol ; 83: 187-192, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31202412

RESUMO

The control of Salmonella in low water activity foods poses a challenge for the food industry because of its thermal resistance. The use of surrogate bacteria in a food plant is considered a critical component to validate processing steps. The objective of this study was to evaluate the use of Pediococcus acidilactici ATCC 8042, a generally recognized as safe bacterium (GRAS), as potential surrogate for Salmonella in commercial toasted oats cereal (TOC) and peanut butter. P. acidilactici was compared to a five-serovar cocktail of Salmonella and Enterococcus faecium NRRL-B2354, separately. Cultures were inoculated into TOC and thermal kinetic parameters (δ, ß) were determined at 80, 85, 90, and 95 °C using the Weibull model. In peanut butter, δ and ß parameters were obtained at 63, 68, 73, and 77 °C. In TOC, the δ values (initial decimal reduction time) of P. acidilactici were 63 and 7 min at 80 and 95 °C, respectively, and at all four temperatures they were not significantly different from δ values of E. faecium. The δ value of Salmonella at 80 °C (139 min) was two-fold greater than the other two bacteria's values (p < 0.05). In peanut butter, δ values of P. acidilactici ranged from 31 min at 63 °C to 2.6 min at 77 °C, and at all temperatures they were not significantly different from E. faecium's δ values. In peanut butter, all Salmonella cocktail's δ values were significantly smaller than P. acidilactici's with values of 2 min at 63 °C and 0.4 min at 77 °C. These results indicated that P. acidilactici was as heat tolerant as E. faecium in these food matrices. However, the thermal inactivation kinetic parameters suggested that P. acidilactici can only be considered a Salmonella surrogate in TOC at temperatures above 85 °C. Because of its greater thermal tolerance in peanut butter, P. acidilactici may be used as Salmonella surrogate if an additional safety factor is recommended.


Assuntos
Arachis/microbiologia , Avena/microbiologia , Microbiologia de Alimentos/métodos , Viabilidade Microbiana , Pediococcus acidilactici/fisiologia , Termotolerância , Contagem de Colônia Microbiana , Qualidade de Produtos para o Consumidor/normas , Temperatura Alta , Cinética , Salmonella/fisiologia
12.
Dermatitis ; 30(2): 116-128, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30829810

RESUMO

BACKGROUND: An essential step in ensuring the toxicological safety of cosmetic or personal care products is the evaluation of the skin sensitizing potential of product ingredients. OBJECTIVE: We used a standardized protocol from cosmetic trade industry and consumer safety groups to evaluate the sensitization potential of ingredients in 3 commercially available cleansing conditioners. METHODS: A total of 33 ingredients were evaluated. Each ingredient underwent (1) dermatological evaluation, (2) in silico analysis for irritation and sensitization potential, and (3) a literature evaluation to determine risk of sensitization. Consumer exposure level was compared with the weight-of-evidence no-expected sensitization induction level for the constituent. If a no-expected sensitization induction level for a specific ingredient was not available, the dermal sensitization threshold approach was used. A margin of safety was calculated for each constituent. RESULTS: The margins of safety for all evaluated ingredients in the cleansing conditioners were greater than 1. CONCLUSIONS: This analysis indicates that exposure to the individual ingredients present in these cleansing conditioners would not be expected to induce dermal sensitization in a consumer under the examined exposure scenario.


Assuntos
Dermatite Alérgica de Contato/etiologia , Preparações para Cabelo/efeitos adversos , Dermatoses do Couro Cabeludo/induzido quimicamente , Higiene da Pele/efeitos adversos , Adulto , Protocolos Clínicos , Simulação por Computador , Qualidade de Produtos para o Consumidor/normas , Feminino , Preparações para Cabelo/toxicidade , Humanos , Medição de Risco , Dermatoses do Couro Cabeludo/etiologia , Higiene da Pele/métodos
13.
J Toxicol Environ Health A ; 82(3): 186-199, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30741122

RESUMO

Safety issues regarding consumer products contaminated with trace amounts of chemicals are of great concern to consumers, with the degree of concern occasionally escalating to the psychological syndrome, chemophobia (i.e., the fear of chemicals). Hazardous substances frequently implicated in safety concerns include heavy metals (arsenic, mercury, cadmium, and lead), volatile organic compounds (VOC) such as benzene and o-toluidine, pesticides, carcinogens, radioactive substances, and endocrine disrupting chemicals (EDC) such as bisphenol A and phthalates. To improve communication of risk to society, members of academia, government, consumer organizations, and industry participated in this workshop to discuss and exchange perspectives on trace chemical safety. From the perspective of academia, integrated risk assessments need to be implemented to encompass various exposure sources and routes. The identification and investigation of new exposure-related biomarkers are also recommended to verify direct causal relationships between specific chemical exposure and effects on human health. As for regulation, governments need to establish and maintain acceptable limits for trace chemicals in products. In addition, harmonized efforts need to be undertaken among government agencies to share regulatory limits and effectively control trace chemicals in consumer products. Manufacturers need to faithfully abide by Good Manufacturing Practice (GMP) guidelines, monitor sources of contamination, and minimize these for consumer safety. To effectively resolve safety issues arising from trace chemicals exposure, collaborative efforts are needed involving academia, government, consumer organizations, and industry. Further, scientific evidence-based risk assessment is a critical approach to effectively manage trace chemical safety issues.


Assuntos
Segurança Química/normas , Qualidade de Produtos para o Consumidor/normas , Exposição Ambiental/efeitos adversos , Substâncias Perigosas/efeitos adversos , Medição de Risco/métodos , Gestão de Riscos/métodos , Oligoelementos/efeitos adversos , Comunicação , Humanos
14.
J Food Prot ; 82(3): 528-534, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30810378

RESUMO

Undercooked poultry is a potential source of foodborne pathogens, such as Salmonella and Campylobacter. The best way to avoid eating undercooked poultry is to use a food thermometer during cooking. However, consumers who cook poultry often use visual appearance for determining doneness, which relies on extrinsic factors, including lighting conditions. Because the United States recently mandated changes in lighting to promote energy conservation, this study evaluated the effect of lighting sources on consumer perceptions of doneness and willingness to eat cooked poultry patties. Consumers ( n = 104) evaluated validated photographs of turkey patties cooked to different end point temperatures (57 to 79°C) and rated the level of perceived doneness and willingness to eat each sample. Evaluations were conducted under different lighting sources: incandescent (60 W, soft white), halogen (43 W, soft white), compact fluorescent lamp (13 W, soft white), light-emitting diode (LED; 10.5 W, soft white), and daylight LED (14 W). Lighting changed perception of doneness and willingness to eat the patties, with some of the energy-efficient options, such as LED and halogen making samples appear more done than they actually were, increasing the willingness to eat undercooked samples. This poses a risk of consuming meat that could contain bacteria not killed by heat treatment. Recent changes in lighting regulations can affect lighting in homes that affects perceptions of poultry doneness, requiring that educators place extra emphasis on the message that properly using a meat thermometer is the only way to ensure meat is cooked to a safe end point temperature.


Assuntos
Qualidade de Produtos para o Consumidor/normas , Culinária/métodos , Iluminação , Produtos Avícolas/normas , Animais , Temperatura Alta , Carne/normas , Aves Domésticas , Perus , Estados Unidos
15.
J Toxicol Environ Health A ; 82(2): 113-127, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30663519

RESUMO

Safety issues regarding consumer products contaminated with trace amounts of chemicals are of great concern to consumers, with the degree of concern occasionally escalating to the psychological syndrome, chemophobia, i.e., the fear of chemicals. Hazardous substances frequently implicated in safety concerns include heavy metals (arsenic, mercury, cadmium, and lead), volatile organic compounds (VOC) such as benzene and o-toluidine, pesticides, carcinogens, radioactive substances, and endocrine disrupting chemicals (EDC) such as bisphenol A and phthalates. To improve communication of risk to society, members of academia, government, consumer organizations, and industry participated in this workshop to discuss and exchange perspectives on trace chemical safety. From the perspective of academia, integrated risk assessments need to be implemented to encompass various exposure sources and routes. The identification and investigation of new exposure-related biomarkers are also recommended to verify direct causal relationships between specific chemical exposure and effects on human health. As for regulation, governments need to establish and maintain acceptable limits for trace chemicals in products. In addition, harmonized efforts need to be undertaken among government agencies to share regulatory limits and effectively control trace chemicals in consumer products. Manufacturers need to faithfully abide by Good Manufacturing Practice (GMP) guidelines, monitor sources of contamination, and minimize these for consumer safety. To effectively resolve safety issues arising from trace chemicals exposure, collaborative efforts are needed involving academia, government, consumer organizations, and industry. Further, scientific evidence-based risk assessment is a critical approach to effectively manage trace chemical safety issues.


Assuntos
Segurança Química/normas , Qualidade de Produtos para o Consumidor/normas , Exposição Ambiental/efeitos adversos , Substâncias Perigosas/efeitos adversos , Medição de Risco/métodos , Gestão de Riscos/métodos , Oligoelementos/efeitos adversos , Comunicação , Humanos
16.
Clin Pharmacol Ther ; 104(3): 423-425, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30120783

RESUMO

The concept of "dietary supplements" is either a blessing for those focused on healthy lifestyles and personal management thereof or a crisis fraught with snake oil and drug analogs that are insidiously poisoning the gullible. Lost in this chatter is the role the ethical, and customer-focused industry takes to drive self-directing/self-governing initiatives to demonstrate unequivocally their position as responsible corporate citizens, meeting the needs of the ever-growing body of wellness-seekers.


Assuntos
Suplementos Nutricionais/normas , Indústria Farmacêutica/normas , Legislação de Medicamentos/normas , Fitoterapia/normas , Preparações de Plantas/normas , Indicadores de Qualidade em Assistência à Saúde/normas , Qualidade de Produtos para o Consumidor/normas , Suplementos Nutricionais/efeitos adversos , Indústria Farmacêutica/legislação & jurisprudência , Regulamentação Governamental , Humanos , Segurança do Paciente/normas , Fitoterapia/efeitos adversos , Preparações de Plantas/efeitos adversos , Formulação de Políticas , Controle de Qualidade , Indicadores de Qualidade em Assistência à Saúde/legislação & jurisprudência , Medição de Risco
17.
Clin Pharmacol Ther ; 104(3): 426-429, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30066384

RESUMO

The United States Pharmacopeia (USP) is an independent, nonprofit, science-based organization whose mission is to improve global health through public quality standards for dietary supplements, medicines, and food ingredients.1 Before developing standards for dietary supplement ingredients, the USP performs an "Admission Evaluation" (Figure 1), which includes an assessment to ascertain that an ingredient does not present a serious health risk.2 This article discusses the challenges encountered during the evaluation of botanicals and proposes possible solutions.


Assuntos
Qualidade de Produtos para o Consumidor/normas , Suplementos Nutricionais/normas , Segurança do Paciente/normas , Farmacopeias como Assunto/normas , Fitoterapia/normas , Preparações de Plantas/normas , Controle de Qualidade , Melhoria de Qualidade/normas , Animais , Suplementos Nutricionais/efeitos adversos , Humanos , Fitoterapia/efeitos adversos , Preparações de Plantas/efeitos adversos , Medição de Risco , Estados Unidos
18.
Toxicol Pathol ; 46(6): 616-635, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-30092727

RESUMO

Colorless, intracytoplasmic vacuoles occur in multiple tissues in animals following repeated administration of polyethylene glycol (PEG)-conjugated molecules. The extent of vacuolation depends on physical characteristics and molecular backbone of the PEG and the dose, product, drug target/pharmacology, and duration of exposure. The collective experience gathered from multiple nonclinical toxicology studies of PEGylated biopharmaceuticals indicates that in general, PEG-related vacuolation is not associated with demonstrable cell and tissue damage or dysfunction and is reversible with sufficient duration of drug-free periods. Existing data are insufficient to predict whether nonclinical animal species differ in their sensitivity to develop PEG-associated vacuoles; however, recent data suggest that there may be species differences. Recent comprehensive reviews have addressed the basic challenges in developing PEGylated pharmaceutical products, including general reference to and description of PEG-associated tissue findings. These manuscripts have identified gaps in our current understanding of PEG-associated vacuolation, including the lack of a widely accepted standardized histological terminology and criteria to record and grade the severity of vacuolation as well as insufficient knowledge regarding the nature of the contents of these vacuoles. The goal of this article is to help address some of the gaps identified above by providing points to consider, including a pictorial review of PEG-associated microscopic findings, when evaluating and reporting the extent, severity, and significance (adversity or lack of adversity) of PEG-associated cytoplasmic vacuolation in safety assessment studies. [Box: see text].


Assuntos
Qualidade de Produtos para o Consumidor/normas , Avaliação Pré-Clínica de Medicamentos/normas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/patologia , Preparações Farmacêuticas/química , Formulação de Políticas , Polietilenoglicóis/toxicidade , Vacúolos/ultraestrutura , Animais , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/etiologia , Especificidade de Órgãos , Preparações Farmacêuticas/metabolismo , Polietilenoglicóis/química , Polietilenoglicóis/farmacocinética , Distribuição Tecidual , Vacúolos/efeitos dos fármacos , Vacúolos/metabolismo
19.
Clin Pharmacol Ther ; 104(3): 446-457, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-29882956

RESUMO

Exposure to botanicals in dietary supplements is increasing across many geographies; with increased expectations from consumers, regulators, and industry stewards centered on quality and safety of these products. We present a tiered approach to assess the safety of botanicals, and an in silico decision tree to address toxicity data gaps. Tier 1 describes a Threshold of Toxicologic Concern (TTC) approach that can be used to assess the safety of conceptual levels of botanicals. Tier 2 is an approach to document a history of safe human use for botanical exposures higher than the TTC. An assessment of botanical-drug interaction (BDI) may also be necessary at this stage. Tier 3 involves botanical chemical constituent identification and safety assessment and the in silico approach as needed. Our novel approaches to identify potential hazards and establish safe human use levels for botanicals is cost and time efficient and minimizes reliance on animal testing.


Assuntos
Qualidade de Produtos para o Consumidor , Suplementos Nutricionais/efeitos adversos , Indústria Farmacêutica , Segurança do Paciente , Fitoterapia/efeitos adversos , Preparações de Plantas/efeitos adversos , Plantas Medicinais/efeitos adversos , Testes de Toxicidade/normas , Animais , Qualidade de Produtos para o Consumidor/normas , Suplementos Nutricionais/normas , Indústria Farmacêutica/normas , Humanos , Segurança do Paciente/normas , Fitoterapia/normas , Preparações de Plantas/normas , Controle de Qualidade , Medição de Risco
20.
Artigo em Alemão | MEDLINE | ID: mdl-29383393

RESUMO

Digital health products and services have started to fundamentally change healthcare and prevention. Products intended for a medical use require CE-marking and potentially certification (ISO 13485) of the company. Startups play an important role in the development of new digital products and services. Two startups share their experience with these processes. Becoming a part of standard care and hence being reimbursed is a challenge for startups. For this reason, startups pursue alternative sources of income, too. The statutory health insurance's procedures for assessing new products and services are perceived as long. Startups are required to provide evidence of the benefit of their product at an early stage in the procedure. This requires time-consuming and costly studies. Startups would therefore appreciate support in generating this evidence, e. g. through adequate procedures for testing.


Assuntos
Qualidade de Produtos para o Consumidor/legislação & jurisprudência , Setor de Assistência à Saúde/legislação & jurisprudência , Programas Nacionais de Saúde/legislação & jurisprudência , Telemedicina/legislação & jurisprudência , Certificação/legislação & jurisprudência , Certificação/normas , Qualidade de Produtos para o Consumidor/normas , Alemanha , Setor de Assistência à Saúde/normas , Humanos , Programas Nacionais de Saúde/normas , Padrão de Cuidado/legislação & jurisprudência , Padrão de Cuidado/normas , Telemedicina/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA